🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06030752
Recruiting Observational

WMT for Autism Spectrum Disorder (ASD)

NCT06030752 · tracked via the Priya Life Science China tracker
Sponsor
The Second Hospital of Nanjing Medical University
Phase
Observational
Started
2023-09-20
Last updated
2026-09-18

Condition(s) studied

Autism Spectrum Disorder

Investigational drug(s) / intervention(s)

Washed Microbiota Transplantation

Washed Microbiota Transplantation: The prepared microbiota suspension was infused into the participates' lower gut.

Study summary

Autism Spectrum Disorder (ASD) is a group of serious neurodevelopmental disorders. A significant comorbidity exists between ADHD and ASD: 30%-50% of individuals with ASD exhibit ADHD symptoms, and two-thirds with ADHD show ASD traits. Intestinal microbial disturbance is common in children with ASD. A great deal of evidence shows that intestinal microbes can influence the brain to play its role through "gut-brain-microbiota axis". We intend to explore the role of Washed Microbiota Transplantation in improving symptoms of children in ASD with or without ADHD; To study the potential etiological mechanism of WMT for the neurodevelopmental disorders.

Eligibility

Sex
ALL
Min age
3 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Children and adolescents with an established diagnosis of ASD or ADHD + ASD according to the Diagnostic and Statistical Manual Of Mental Disorders Fifth Edition;. * Age 3-17 years. * Received stable treatments for ≥1 month preceding WMT Exclusion Criteria: * Their guardian could not understand the questionnaires or provide informed consent. * Diagnosed with a single-gene disorder, major brain malformations, gastrointestinal diseases (ulcerative colitis, Crohn's disease, or eosinophilic esophagitis) * Had severe comorbidities including cardiopulmonary failure, severe liver, and kidney diseases, severe infection, tumors, etc. * Accompanied with other life-threatening disorders required emergency treatment. * Unable to tolerate colonoscopy or anesthesia.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu Recruiting
SIR RUN RUN hospital of Nanjing Medical University Nanjing Jiangsu Recruiting

More The Second Hospital of Nanjing Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06030752 on ClinicalTrials.gov ↗ ← All trials in China